Press Releases

INEOS and Solvay reach agreement for divestment of remedy business to ICIG


INEOS and Solvay have reached an agreement with International Chemical Investors Group (ICIG) to acquire the assets being divested by INEOS. This agreement, which follows extensive discussions with the European Commission in the context of the merger control review of INOVYN, is a key step towards completion of the INOVYN project.

ICIG is a privately held industrial company (headquartered in Luxembourg and Germany) that specialises in chemicals and pharmaceuticals, with 23 manufacturing sites across Europe and the United States.

The assets being divested ("the remedy business") consist of:

  • the chlorine plants and EDC/ VCM plants at Tessenderlo, Belgium (excluding the chlorotoluenes business that will remain with INEOS);
  • the PVC plant at Mazingarbe, France;
  • the PVC plant at Beek, the Netherlands;the PVC and VCM plants at Wilhelmshaven, Germany; 
  • and the EDC plants at Runcorn, UK.

In addition, the membrane chlorine plant at Runcorn is to be placed in a 50/ 50 Joint Venture between INOVYN and ICIG. The divestment will also include a portion of the potassium hydroxide (KOH) business at Tessenderlo, with ICIG supplying INOVYN under a toll manufacturing arrangement for the proportion of the KOH business that INOVYN will retain.

It is anticipated that the formation of INOVYN will take place in the second quarter of 2015, upon receipt of all required regulatory approvals and completion of consultation with relevant INEOS employees in scope of the proposed divestment.


Contacts at INEOS

Richard Longden
Media Relations
T: + 41 216 277 063

Craig Welsh
Media Relations
T: + 44 19 28 511 528

Louise Calviou
Investor Relations
T: + 44 1928 516 644

Contacts at Solvay

Lamia Narcisse
Media Relations
T: + 33 1 53 56 59 62

Caroline Jacobs
Media Relations
T: + 32 2 264 1530

Maria Alcon-Hidalgo
Investor Relations
T: + 32 2 264 1984

Edward Mackay 
Investor Relations
T: + 32 2 264 36 87

Share this Article: